MAO Li-wei,WANG Wei-dong,LI De-zhi,CHEN Zheng-tang.Construction of eukaryotic expression vector of pE6/p53/GFP and its influence on cell cycle of lung adenocarcinoma[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(24):2323-2326.
MAO Li-wei,WANG Wei-dong,LI De-zhi,CHEN Zheng-tang.Construction of eukaryotic expression vector of pE6/p53/GFP and its influence on cell cycle of lung adenocarcinoma[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(24):2323-2326.DOI:
Objective To construct the wt-p53’s eukaryotic expression vector pE
6
/p53/GFP that was controlled by the radiation induced promoter and research its functions. Methods Radiation response element E
6
was synthesized by gene synthesis. The wt-p53 cDNA sequence was prepared from pcDNA3.1(+)/p53 plasmid by PCR. IRES
2
-EGFP report gene segment was prepared from double cistron expression vector IRES
2
-E
GFP by enzyme digestion. After sequenced and identified
the recombinant plasmid was transformed into H1299(p53
-/-
) cell with Lipofectamine 2000
and the cell lines in stable expression was screened by G418. In the H1299(p53
-/-
) cell transfected with the recombinant plasmid or without
wt-p53 mRNA expression was analyzed by RT-PCR
the p53 expression by Western blot when exposed to 4 Gy 8 MV X ray for 0
3
8
12
24
36 h or when exposed to 0
1
2
4
8 Gy 8 MV X ray for 12 h. The cell cycle of H1299(p53
-/-
) cell transfected stably with the recombinant vector was analyzed by flow cytometry after exposed to 4 Gy 8 MV X ray. Results The recombinant pE
6
p53/GFP plasmid had been constructed correctly and the expression of p53 gene in the transfected H1299 cell lines had been determined. After 4 Gy X ray radiation
the expression of wt-p53 protein had a significant rise. The transfected H1299 cell lines stopped in G
1
stage after radiation and their cloning efficiency decreased notably. Conclusion We had constructed successfully the recombinant pE
6
/p53/GFP plasmid that was regulated by radiation induced response element E6. This provides experimental data for radiation-gene therapy of non-small lung cancer.